
Keyuan Pharma's application for additional issuance related to acquisition matters has been accepted by the Shenzhen Stock Exchange

I'm PortAI, I can summarize articles.
According to the Zhitong Finance APP, Keyuan Pharma announced that on June 27, 2025, it received a notice from the Shenzhen Stock Exchange regarding the acceptance of the application documents for the issuance of shares to purchase assets and raise supporting funds by Shandong Keyuan Pharmaceutical Co., Ltd. The Shenzhen Stock Exchange verified the application documents submitted by the company, deemed them complete, and decided to accept them
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

